Vaccinex plans to delist common stock from Nasdaq
Source: SeekingAlpha
2025-03-07 17:21:56 ET
More on Vaccinex
- Vaccinex receives delisting notice from Nasdaq, shares down over 49%
- Financial information for Vaccinex
Read the full article on Seeking Alpha
For further details see:
Vaccinex plans to delist common stock from Nasdaq
Vaccinex Inc.
NASDAQ: VCNX
VCNX Trading
-12.74% G/L:
$1.27 Last:
1,416 Volume:
$1.195 Open:
VCNX Latest News
December 23, 2025 10:43:00 am
Micro Cap Biotech Secures $60M to Advance Alzheimer's Treatment, Shares Surge
December 23, 2025 08:01:00 am
Vaccinex, Inc. Announces $60 million Agreement to Finance a Phase 2b clinical trial of pepinemab to treat Alzheimer's Disease
VCNX Stock Data
$3,185,198
1,198,474
33.95%
8
71159%
Biotechnology & Life Sciences
Healthcare
US
Rochester
